» Articles » PMID: 22469801

The Long-term Clinical Course of Pouchitis After Total Proctocolectomy and IPAA for Ulcerative Colitis

Overview
Specialty Gastroenterology
Date 2012 Apr 4
PMID 22469801
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pouchitis is the most common long-term complication after restorative total proctocolectomy and IPAA for ulcerative colitis.

Objective: We examined the incidence, clinical aspects, and long-term outcome of patients with idiopathic pouchitis.

Design: This study was a retrospective review of medical records.

Patients: Included in the study were 284 patients with ulcerative colitis who underwent a total proctocolectomy and IPAA.

Main Outcome Measures: We evaluated the cumulative risk and long-term outcome of pouchitis including the duration of disease, pattern of relapse, and responsiveness to antibiotic therapy.

Results: Sixty-four patients developed idiopathic pouchitis. The cumulative risk was 10.7% at 1 year, 17.2% at 2 years, 24.0% at 5 years, and 38.2% at 10 years. At their first pouchitis episode, 45 patients had acute pouchitis, 19 patients had chronic pouchitis, and all patients received antibiotic therapy with oral ciprofloxacin and/or metronidazole. The efficacy of the therapy was 96.6% initially. Forty-five patients had antibiotic-responsive pouchitis, 17 patients had antibiotic-dependent pouchitis, and 2 patients had antibiotic-refractory pouchitis at their first episode. Whereas 20 of 45 patients (44.4%) with initially acute pouchitis experienced 2 or more relapses, 16 of 19 patients (84.2%) with initially chronic pouchitis had 2 or more relapses. After taking into account the relapses, the number of patients with antibiotic-responsive pouchitis decreased from 45 to 40, the number with antibiotic-dependent pouchitis increased from 17 to 20, and the number with antibiotic-refractory pouchitis increased from 2 to 4. Among the 4 patients with antibiotic-refractory pouchitis, 3 patients had Clostridium difficile-associated pouchitis.

Limitations: This study was retrospective.

Conclusion: The patients with chronic pouchitis at the first episode tend to have a higher incidence of relapse. In some patients, the responsiveness to antibiotic therapy changes during follow-up. When patients with pouchitis do not respond to standard antibiotic therapy, then the occurrence of C difficile infection should be considered.

Citing Articles

Safety of transanal ileal pouch-anal anastomosis for ulcerative colitis: a retrospective observational cohort study.

Lask A, Biebl M, Dittrich L, Fischer A, Adler A, Tacke F Patient Saf Surg. 2021; 15(1):31.

PMID: 34537080 PMC: 8449900. DOI: 10.1186/s13037-021-00306-5.


Is Ustekinumab Effective in Refractory Crohn's Disease of the Pouch and Chronic Pouchitis? A Systematic Review.

Rocchi C, Soliman Y, Massidda M, Vadala di Prampero S, Bulajic M, Sorrentino D Dig Dis Sci. 2021; 67(6):1948-1955.

PMID: 34097166 DOI: 10.1007/s10620-021-07002-5.


Disease and Treatment Patterns Among Patients With Pouch-related Conditions in a Cohort of Large Tertiary Care Inflammatory Bowel Disease Centers in the United States.

Barnes E, Raffals L, Long M, Syal G, Kayal M, Ananthakrishnan A Crohns Colitis 360. 2020; 2(3):otaa039.

PMID: 32744536 PMC: 7380550. DOI: 10.1093/crocol/otaa039.


Early colectomy in steroid-refractory acute severe ulcerative colitis improves operative outcome.

Saha S, Panwar R, Kumar A, Pal S, Ahuja V, Dash N Int J Colorectal Dis. 2017; 33(1):79-82.

PMID: 28920181 DOI: 10.1007/s00384-017-2903-8.


Management of inflammatory bowel disease with infection.

Daoust J, Battat R, Bessissow T World J Gastroenterol. 2017; 23(27):4986-5003.

PMID: 28785153 PMC: 5526769. DOI: 10.3748/wjg.v23.i27.4986.